These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 12875898)

  • 1. Free radical mediated peroxidative damage in systemic lupus erythematosus.
    Kurien BT; Scofield RH
    Life Sci; 2003 Aug; 73(13):1655-66. PubMed ID: 12875898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased levels of autoantibodies against catalase and superoxide dismutase associated with oxidative stress in patients with rheumatoid arthritis and systemic lupus erythematosus.
    Mansour RB; Lassoued S; Gargouri B; El Gaïd A; Attia H; Fakhfakh F
    Scand J Rheumatol; 2008; 37(2):103-8. PubMed ID: 18415766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced reactivity to malondialdehyde-modified proteins by systemic lupus erythematosus autoantibodies.
    Ben Mansour R; Lassoued S; Elgaied A; Haddouk S; Marzouk S; Bahloul Z; Masmoudi H; Attia H; Aïfa MS; Fakhfakh F
    Scand J Rheumatol; 2010 May; 39(3):247-53. PubMed ID: 20429675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxidative stress in systemic lupus erythematosus: relationship to Th1 cytokine and disease activity.
    Shah D; Kiran R; Wanchu A; Bhatnagar A
    Immunol Lett; 2010 Mar; 129(1):7-12. PubMed ID: 20105444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipid peroxidation in systemic lupus erythematosus.
    Kurien BT; Scofield RH
    Indian J Exp Biol; 2006 May; 44(5):349-56. PubMed ID: 16708886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunological studies of oxidized superoxide dismutase in patients with systemic lupus erythematosus. Correlation with disease induction and progression.
    Al-Shobaili HA; Rasheed Z
    Saudi Med J; 2012 Nov; 33(11):1177-84. PubMed ID: 23147873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential oxidative modification of proteins in MRL+/+ and MRL/lpr mice: Increased formation of lipid peroxidation-derived aldehyde-protein adducts may contribute to accelerated onset of autoimmune response.
    Wang G; Li H; Firoze Khan M
    Free Radic Res; 2012 Dec; 46(12):1472-81. PubMed ID: 22950782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of lipid peroxides and superoxide dismutase on systemic lupus erythematosus: a preliminary study.
    Jiang X; Chen F
    Clin Immunol Immunopathol; 1992 Apr; 63(1):39-44. PubMed ID: 1591881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased levels of autoantibodies against apolipoprotein B-100 antigens are associated with cardiovascular disease in systemic lupus erythematosus.
    Svenungsson E; Engelbertsen D; Wigren M; Gustafsson JT; Gunnarsson I; Elvin K; Jensen-Urstad K; Fredrikson GN; Nilsson J
    Clin Exp Immunol; 2015 Sep; 181(3):417-26. PubMed ID: 25959453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential clearance mechanisms, neutrophil extracellular trap degradation and phagocytosis, are operative in systemic lupus erythematosus patients with distinct autoantibody specificities.
    Chauhan SK; Rai R; Singh VV; Rai M; Rai G
    Immunol Lett; 2015 Dec; 168(2):254-9. PubMed ID: 26434792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoimmune reactivity to malondialdehyde adducts in systemic lupus erythematosus is associated with disease activity and nephritis.
    Hardt U; Larsson A; Gunnarsson I; Clancy RM; Petri M; Buyon JP; Silverman GJ; Svenungsson E; Grönwall C
    Arthritis Res Ther; 2018 Feb; 20(1):36. PubMed ID: 29482604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reactive oxygen species, lipid peroxides and essential fatty acids in patients with rheumatoid arthritis and systemic lupus erythematosus.
    Suryaprabha P; Das UN; Ramesh G; Kumar KV; Kumar GS
    Prostaglandins Leukot Essent Fatty Acids; 1991 Aug; 43(4):251-5. PubMed ID: 1658811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction between oxidative stress and chemokines: possible pathogenic role in systemic lupus erythematosus and rheumatoid arthritis.
    Shah D; Wanchu A; Bhatnagar A
    Immunobiology; 2011 Sep; 216(9):1010-7. PubMed ID: 21601309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different end-points to assess effects in systemic lupus erythematosus patients exposed to pesticide mixtures.
    Simoniello MF; Contini L; Benavente E; Mastandrea C; Roverano S; Paira S
    Toxicology; 2017 Feb; 376():23-29. PubMed ID: 27497885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipid peroxidation is enhanced in patients with systemic lupus erythematosus and is associated with arterial and renal disease manifestations.
    Frostegård J; Svenungsson E; Wu R; Gunnarsson I; Lundberg IE; Klareskog L; Hörkkö S; Witztum JL
    Arthritis Rheum; 2005 Jan; 52(1):192-200. PubMed ID: 15641060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel autoantibody to Cu/Zn superoxide dismutase in patients with localized scleroderma.
    Nagai M; Hasegawa M; Takehara K; Sato S
    J Invest Dermatol; 2004 Mar; 122(3):594-601. PubMed ID: 15086540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antihistones antibodies in systemic lupus erythematosus, comparison of three assays: Elisa, dot blot and immunoblot].
    Ghedira I; Landolsi H; Mankai A; Fabien N; Jeddi M
    Pathol Biol (Paris); 2006 Apr; 54(3):148-54. PubMed ID: 16169158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoantibodies against protective molecules--C1q, C-reactive protein, serum amyloid P, mannose-binding lectin, and apolipoprotein A1: prevalence in systemic lupus erythematosus.
    Shoenfeld Y; Szyper-Kravitz M; Witte T; Doria A; Tsutsumi A; Tatsuya A; Dayer JM; Roux-Lombard P; Fontao L; Kallenberg CG; Bijl M; Matthias T; Fraser A; Zandman-Goddard G; Blank M; Gilburd B; Meroni PL
    Ann N Y Acad Sci; 2007 Jun; 1108():227-39. PubMed ID: 17899624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IgM antibodies against malondialdehyde and phosphorylcholine are together strong protection markers for atherosclerosis in systemic lupus erythematosus: Regulation and underlying mechanisms.
    Rahman M; Sing S; Golabkesh Z; Fiskesund R; Gustafsson T; Jogestrand T; Frostegård AG; Hafström I; Liu A; Frostegård J
    Clin Immunol; 2016 May; 166-167():27-37. PubMed ID: 27102765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. OxLDL/beta2GPI complexes and autoantibodies in patients with systemic lupus erythematosus, systemic sclerosis, and antiphospholipid syndrome: pathogenic implications for vascular involvement.
    Lopez LR; Simpson DF; Hurley BL; Matsuura E
    Ann N Y Acad Sci; 2005 Jun; 1051():313-22. PubMed ID: 16126973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.